Nuvectis Pharma, Inc.
NVCT
$9.44
-$0.05-0.53%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 18.53M | 17.17M | 18.12M | 19.46M | 19.13M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 74.00K | 138.00K | 182.00K | 250.00K | 59.00K |
Total Current Assets | 18.61M | 17.31M | 18.30M | 19.71M | 19.19M |
|
|||||
Total Current Assets | 18.61M | 17.31M | 18.30M | 19.71M | 19.19M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 18.61M | 17.31M | 18.30M | 19.71M | 19.19M |
|
|||||
Total Accounts Payable | 2.50M | 2.26M | 1.85M | 1.76M | 2.77M |
Total Accrued Expenses | 6.40M | 4.06M | 3.92M | 3.93M | 4.21M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 8.89M | 6.32M | 5.77M | 5.69M | 6.98M |
|
|||||
Total Current Liabilities | 8.89M | 6.32M | 5.77M | 5.69M | 6.98M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 8.89M | 6.32M | 5.77M | 5.69M | 6.98M |
|
|||||
Common Stock & APIC | 82.96M | 77.99M | 75.37M | 72.44M | 66.45M |
Retained Earnings | -73.25M | -67.00M | -62.84M | -58.42M | -54.25M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 9.71M | 10.99M | 12.53M | 14.02M | 12.20M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 9.71M | 10.99M | 12.53M | 14.02M | 12.20M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 9.71M | 10.99M | 12.53M | 14.02M | 12.20M |
|